FORMULATION AND OPTIMIZATION OF MUCOADHESIVE MICROSPHERES OF VALSARTAN BY USING BOX-BEHNKEN DESIGN

  • CHIMAN LAL I. K. G. Punjab Technical University, Kapurthala 144603, Punjab, India
  • RAJEEV GARG Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India 140111
  • GHANSHYAM DAS GUPTA I. S. F. College of Pharmacy, Moga, Punjab, India 142001

Abstract

Objective: The purpose of this study was to formulate and optimize mucoadhesive microspheres of antihypertensive drug (valsartan) within ethyl cellulose as a carrier polymer and carbopol 934P as a mucoadhesive polymer for controlling the release of valsartan.


Methods: The emulsion solvent evaporation technique was used for preparation of microspheres of valsartan and the Box-Behnken design was employed with thee independent variables that is amount of ethyl cellulose (X1) and amount of carbopol 934P (X2) and stirring speed (X3) and evaluate four dependent variables such as percentage mucoadhesion, Q1 h, t90% and drug entrapment efficiency.


Results: The optimum conditions were found to be X1= 200 mg, X2= 107 mg and X3= 1200rpm. The optimized batch exhibited a high drug entrapment efficiency of 85.63±1.384%, percentage mucoadhesion was 66.76±0.986% and drug release was also sustained for more than 12 h.


Conclusion: The analysis of variance showed a significant effect of independent variables. The scaning electron microscopy (SEM) analysis showed that the microspheres were spherical and free-flowing. The microspheres of valsartan were stable after thee month stability study at accelerated condition.

Keywords: Mucoadhesive microspheres, Valsartan, Carbopol 934P, Ethyl cellulose, Box-Behnken design

References

1. Rahman AM, Hasan R. Hypertension and associated risk factors in some selected rural areas of Bangladesh. Int J Res Med Sci 2014;2:925.
2. Misha CP, Kumar S. Risk factors of hypertension in a rural area of Varanasi. Indian J Prev Soc Med 2011;42:101–11.
3. Abebe SM. Prevalence and associated factors of hypertension: a crossectional community-based study in Northwest Ethiopia. PLoS One 2015;10:1-11.
4. Pardeshi CV. Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for valsartan. J Microencapsul 2012;29:103–14.
5. Singh S. Prevalence and associated risk factors of hypertension: a cross-sectional study in urban varanasi hindawi. Int J Hypertens 2017;1-10. https://doi.org/10.1155/2017/5491838
6. Tabrizi JS. Prevalence and associated factors of prehypertension and hypertension in Iranian population: the lifestyle promotion project (LPP). PLoS One 2016;11:1-15.
7. Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res 2015;116:1074-95.
8. Saydam M, Takka S. Bioavailability file: valsartan. J Pharm Sci 2007;32:185–96.
9. Siddiqui N. Pharmacological and pharmaceutical profile of valsartan: a review. J Appl Pharm Sci 2011;1:12–9.
10. Shukla S. Formulation and in vitro characterization of alginate microspheres loaded with diloxanide furoate for colon-specific drug delivery. Asian J Pharm 2010;4:199-204.
11. Kakkar R. Formulation and characterization of valsartan proniosomes. Int J Sci Tech 2010;5:146–58.
12. Moffat AC. Clarke’s analysis of drugs and poisons. London, UK: Pharmaceutical Press; 2003;3:1692–3.
13. Garud A. Valsartan microcapsules with a coat consisting of alginate and natural cationic polymers. J Pharm Res 2010. p. 271-96.
14. Hagerstorm H. Polymer gels as pharmaceutical dosage forms. Ph. D. Thesis, Faculty of Pharmacy, Uppasala University, Sweden; 2003.
15. Dua K, Trivedi P. Formulation and evaluation of mucoadhesive microspheres of ranitidine hydrochloride using chitosan and sodium carboxymethyl cellulose as polymers. Int J Biomed Res 2013;4:140–4.
16. Ben HL. Bioadhesive polymers for the per-oral delivery of peptide drugs. J Controlled Release 1994;29:329–38.
17. Ben HL. Mucoadhesive excipients for the per-oral delivery of peptide drugs. Eur J Pharm Biopharm 1996;4:117–28.
18. Henriksen I. Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int J Pharm 1996;145:231–40.
19. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and haemostatic potential. J Biomed Mater Res 1997;34:21–8.
20. Kyada C. Optimization of mucoadhesive microspheres of acyclovir by applying 32 full factorial design. J Drug Delivery Sci Tech 2014;24:61-8.
21. Patel J. Formulation and evaluation of propranolol hydrochloride-loaded carbopol-934P/ethyl cellulose mucoadhesive microspheres. Iran J Pharm Res 2010;9:221-32.
22. Satriani AP. Application of box-behnken design in the optimization of glucose production from oil palm empty fruit bunch cellulose. Int J Polym Sci 2013;1-8. http://dx.doi.org/ 10.1155/ 2013/104502.
23. Chowdary KPR, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizid for oral controlled release a technical note. AAPS PharmSciTech 2003;4:87-92.
24. Jadhav SA, Sharma Y. Mucoadhesive microsphere. Indo Am J Pharm Res 2015;5:3459-70.
25. Yadav VK. Design and evaluation of mucoadhesive microspheres of repaglinide for oral controlled release. Int J Drug Delivery 2011;3:357-70.
26. Abd El-Hameed MD, Kellaway IW. Preparation and in vitro characterization of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur J Pharm Biopharm 1997;44:53–60.
27. Kaushik AY. Preparation of floating microspheres of valsartan: in vitro characterization. Int J Res Aurveda Pharm 2015;6:124-30.
28. Desai S. Preparation and in vitro characterization of mucoadhesive microspheres of midazolam: nose to brain administration. Asian J Pharm Clin Res 2011;4:100-2.
29. Khan AB, Thakur RS. Formulation and evaluation of mucoadhesive microspheres of tenofovir disoproxil fumarate for intravaginal use. Curr Drug Delivery 2014;11:112-22.
30. Khan R. Formulation and evaluation of mucoadhesive microspheres of flurbiprofe. Pharmacologyonline3 2010;4:1560-6.
31. Garg R, Gupta GD. Gastroretentive floating microspheres of silymarin: preparation and in vitro evaluation. Trop J Pharm Res 2010;9:59-66.
32. Deshmukh MT, Mohite SK. Formulation and characterization of olanzepine-loaded mucoadhesive microspheres. Asian J Pharm Clin Res 2017;10:249-55.
33. Velmurugan S, Ali MA. Development and evaluation of ritonavir mucoadhesive microspheres. Asian J Pharm Clin Res 2014;7:47-52.
34. Nappinnai M, Sivaneswari S. Formulation optimization and characterization of gastroretentive cefpodoxime proxetil mucoadhesive microspheres using 32 factorial design. J Pharm Res 2013;7:304-9.
35. Singh B. Correction of raw dissolution data for loss of drug and volume during sampling. Indian J Pharm Sci 1997;59:196-9.
36. Hoodaa A. Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software. Int J Biol Macromol 2012;51:691–700.
37. Sabiu S. Indomethacin-induced gastric ulceration in rats: protective roles of spondias mombin and ficus exasperate. J Toxicol Pharmacol 2015;2:261-7.
38. Leh CM. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-a comparative study with copolymers and blends based on poly (acrylic acid). J Controlled Release 1990;13:51-62.
39. Hardenia SS. Formulation and evaluation of mucoadhesive microspheres of ciprofloxacin. J Adv Pharm Edu Res 2011;1:214-24.
40. Ritger PL, Peppas NA. A simple equation for description of solute release II Fickian and anomalous release from swellable devices. J Controlled Release 1987;5:37-42.
41. Ige PP, Gattani SG. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note. Arch Pharm Res 2012;35:487-98.
42. Dey S. Formulation and optimization of sustained release stavudine microspheres using response surface methodology. ISRN Pharm 2011. p. 1-7.
43. Maiti S. Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique, AAPS PharmSciTechnol 2009;10:703–15.
44. Venkatesan P. Preparation and evaluation of sustained release loxoprofen loaded microspheres. J Basic Clin Pharmacol 2011;2:159–62.
45. Fu X. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsul 2005;22:57-66.
46. Kohl S. Ethylcellulose floating microspheres of antidiabetic agent: in vitro and in vivo evaluation. Int J Appl Pharm 2017;9:44-9.
47. Chickering D. Bioadhesive microspheres: characterization and evaluation of bioadhesion involving hard, biodegradable polymers and soft tissue. Reactive Polymers 1995;25:198-206.
Statistics
108 Views | 90 Downloads
Citatons
How to Cite
LAL, C., GARG, R., & GUPTA, G. D. (2019). FORMULATION AND OPTIMIZATION OF MUCOADHESIVE MICROSPHERES OF VALSARTAN BY USING BOX-BEHNKEN DESIGN. International Journal of Applied Pharmaceutics, 11(4), 371-379. https://doi.org/10.22159/ijap.2019v11i4.33710
Section
Original Article(s)